CCHR Supports Suspension of NY Psychiatric Institute Research After Suicide
Aug 24, 2023
Mental health watchdog commends halt of New York Psychiatric Institute research following patient suicide, stresses need for reform
Los Angeles, United States - August 24, 2023 /PressCable/ —
The Citizens Commission on Human Rights (CCHR) applauded the recent federal government decision to suspend research on human subjects at the New York State Psychiatric Institute (NYSPI) in the wake of a tragic suicide during a clinical drug trial. The Parkinson’s Disease drug was being tested to treat depression.[1] Concerns are now raised about the institute’s safety protocols and research practices, specifically relating to the management of participants on antidepressants during the trial, the withdrawal procedures, and their potential role in the tragic event.[2] The psychiatrist who led the study resigned from NYSPI on June 1, 2023, and is no longer a Columbia faculty member.[3]
The Department of Health and Human Services’ Office for Human Research Protections (OHRP) initiated the suspension of research funding to NYSPI, affiliated with Columbia University, citing the need to thoroughly investigate the circumstances surrounding the patient’s suicide and the institute’s overall safety measures.[4]
According to The New York Times, “It is unusual for the U.S. regulatory office to suspend research, and this suggests that investigators are concerned that potential violations of safety protocols occurred more broadly within the institute.” The NYSPI, which shares buildings and staff with Columbia University and the University’s hospital, has been conducting nearly 500 research studies with a budget of $86 million—of those, 124 receive federal funding.[5]
This decision to halt all human research follows the removal of a former American Psychiatric Association psychiatrist as the director of NYSPI in 2022. The removal occurred due to public remarks he had made of a racist nature. Subsequently, an interim leader in the field of psychiatry was appointed director. However, that interim leader was then succeeded by yet another psychiatrist in response to the University’s suspension of the clinical trials because of the suicide.[6]
The study received $736,579 in funding from the National Institute of Mental Health.[7]
CCHR joins others in questioning the handling of participants who were taking antidepressants prior to the trial, including how they were withdrawn from these drugs and whether such withdrawals were responsible for the tragic outcome.[8]
A former research assistant who managed the clinical trial in its first year told Spectrum that recruiting was challenging—and in a bid to get enough people enrolled, some criteria were “relaxed.”[9]
According to Spectrum, “Participants who met all the enrollment criteria but were taking an…antidepressant were supposed to undergo a study-supervised taper of that medication and complete a washout period, though that was not explicitly written into the publicly available study protocol.”[10]
While Daily Mail reported that it is not yet confirmed if the deceased person was taking antidepressants, it said, “Issues became apparent after it was reported that some of the human subjects had only just finished taking their antidepressants days earlier, which goes against the study’s protocol. As well as this, stopping antidepressant consumption is linked to an increased risk of suicide.”[11]
The lead psychiatrist running the halted study had four previously published studies retracted or corrected for issues related to how
participants taking antidepressants at enrollment were handled. One retraction notice published in February 2023 indicated that tapering could be challenging and that the researchers did not always stick to the protocol. One-third of the participants taking antidepressants were unable to successfully taper off them.[12]
Withdrawal effects, as highlighted in a 2019 Epidemiology and Psychiatric Science study, can last weeks to months.[13] Withdrawal symptoms can encompass potentially violent and suicidal symptoms.[14] The UK Royal College of Psychiatrists has also cautioned about experiencing anxiety, “sometimes in intense ‘surges,’” rapidly changing moods, anger, suicidal thoughts and a feeling of inner restlessness and inability to stay still (akathisia), with the latter capable of leading to violence.[15]
Columbia University’s research history is marred by the findings of investigations into its practices and that of NYSPI.
In the 1950s, NYSPI conducted LSD experiments under the Central Intelligence Agency’s guidance, tragically leading to the death of a patient, Harold Blauer, who was injected with mescaline.[16]
In 1998, NYSPI-Columbia faced an inquiry for subjecting vulnerable youth to hazardous fenfluramine (a drug normally used to treat seizures) trials as part of the “Fen-Phen” diet drug combination, where children were subjected to unethical and damaging experiments.[17]
In 1999, the New York Post, through documents obtained under the Freedom of Information Act, exposed that NYSPI researchers conducted tests using an SSRI antidepressant on children as young as six, without fully informing parents or guardians of the dangers involved.[18]
In 2016, then chair of the Department of Psychiatry at Columbia and NYSPI’s director downplayed the severe adverse effects of psychedelic drugs. A 2023 University of London report found serious ongoing negative impacts from the drugs, such as anxiety, fear, existential struggles, and more.[19]
CCHR says these instances and the ongoing investigations into potential protocol breaches underscore a problematic culture that persists despite previous controversies. They highlight the need for robust oversight, accountability, and substantial penalties for NYSPI and Columbia University’s psychiatric research violations.
[1] www.nytimes.com/2023/08/10/health/columbia-drug-trials-suicide.html
[2] www.dailymail.co.uk/news/article-12395401/New-York-State-Psychiatric-Institute-suicide-Parkinsons.html; www.spectrumnews.org/news/exclusive-shake-up-at-top-psychiatric-institute-following-suicide-in-clinical-trial/
[3] www.medscape.com/viewarticle/995413
[4] www.medscape.com/viewarticle/995413
[5] www.nytimes.com/2023/08/10/health/columbia-drug-trials-suicide.html
[6] www.medscape.com/viewarticle/995413; www.spectrumnews.org/news/exclusive-shake-up-at-top-psychiatric-institute-following-suicide-in-clinical-trial/; “After reported suicide of participant, human research studies suspended at psychiatric institute affiliated with Columbia University,” CNN, 11 Aug. 2023
[7] www.dailymail.co.uk/news/article-12395401/New-York-State-Psychiatric-Institute-suicide-Parkinsons.html
[8] www.dailymail.co.uk/news/article-12395401/New-York-State-Psychiatric-Institute-suicide-Parkinsons.html; www.spectrumnews.org/news/exclusive-shake-up-at-top-psychiatric-institute-following-suicide-in-clinical-trial/
[9] www.dailymail.co.uk/news/article-12395401/New-York-State-Psychiatric-Institute-suicide-Parkinsons.html
[10www.spectrumnews.org/news/exclusive-shake-up-at-top-psychiatric-institute-following-suicide-in-clinical-trial/
[11www.dailymail.co.uk/news/article-12395401/New-York-State-Psychiatric-Institute-suicide-Parkinsons.html
[12] www.spectrumnews.org/news/exclusive-shake-up-at-top-psychiatric-institute-following-suicide-in-clinical-trial/
[13] www.cchrint.org/2021/04/06/antidepressant-withdrawal-warning-vital/, citing www.ncbi.nlm.nih.gov/pmc/articles/PMC8061160/
[14] www.verywellmind.com/antidepressant-withdrawal-4172110; www.madinamerica.com/2022/10/antidepressant-withdrawal-linked-suicide-attempt-case-study/
[15] www.rcpsych.ac.uk/mental-health/treatments-and-wellbeing/stopping-antidepressants
[16] nypost.com/2019/09/16/the-mad-scientist-behind-americas-mind-control-quest-with-lsd/; ahrp.org/nypsi-an-early-cia-contracted-academic-institution-under-mk-naomi/
[17] www.psychiatrictimes.com/view/americas-tragedy; www.nature.com/articles/33760
[18] Greg Birnbaum, “Science or Abuse? State Testing,” New York Post, 31 Jan. 1999
[19] journals.sagepub.com/doi/10.1177/0269881116675755; papers.ssrn.com/sol3/papers.cfm?abstract_id=4505228
Contact Info:
Name: Amber Rauscher
Email: Send Email
Organization: Citizens Commission on Human Rights International
Address: 6616 Sunset Boulevard, Los Angeles, California 90028, United States
Phone: +1-323-467-4242
Website: https://www.cchrint.org
Source: PressCable
Release ID: 89105701
If you encounter any issues, discrepancies, or concerns regarding the content provided in this press release, or if there is a need for a press release takedown, we urge you to notify us without delay at [email protected]. Our expert team will be available to promptly respond within 8 hours – ensuring swift resolution of identified issues or offering guidance on removal procedures. Delivering accurate and reliable information is fundamental to our mission.
More News
As the US weighs restrictions on cloud computing, how will China’s AI sector adapt?
When Chinese artificial intelligence developers want to train their next-generation frontier models, they all face the same daunting wall: they cannot legally buy the world’s most powerful AI chips. However, the country’s tech giants and start-ups have still managed to quietly keep pace with global rivals. Their secret is an elusive workaround: moving heavy training workloads across borders through the cloud. By setting up proxy entities in foreign jurisdictions, domestic firms have for years...
South Korea steps up to plug Europe’s jet fuel deficit
Europe faces a fourth-quarter jet fuel deficit, even as it turns to far-flung suppliers including South Korea, which is set to boost its jet exports to Europe to a four-year high in September, according to analysts and shipping data. The continent has been importing more jet fuel from nations including Nigeria, the United States and Canada since the outbreak of the Iran war over half a year ago, which hit Middle Eastern supplies and cut off around half of Europe’s jet imports. Europe remains...
Chinese AI chipmaker Hygon plots expansion from data centres to robotics
Chinese chipmaker Hygon Information Technology is set to release a new chip targeting physical-world applications including robotics, expanding from its current focus on data centres, according to Chinese media reports and company information. The product launch, slated for Tuesday, marks Hygon’s move into a new chip category powering machines that interact directly with their environments, as physical artificial intelligence becomes increasingly important. The new chip, an iteration of the...
Upgraded but underperforming: Philippines’ growth lags behind
The Philippines’ rise to upper-middle-income status was supposed to mark a new phase for one of Southeast Asia’s most closely watched emerging economies. Instead, analysts say the milestone has done little to shield the country from short-term pressures weighing on growth: sluggish public spending, delayed infrastructure, high living costs and the fallout from investigations into alleged irregularities in flood control projects. Those strains have left the Philippines looking like a regional...
Pacific island states are trapped in Cold War 2.0
In early July, China fired a test missile from a nuclear submarine into the South Pacific for the first time, a weapon capable of carrying nuclear warheads. Washington and Canberra were livid. The Pacific has long been the exclusive testing ground for such long-range missiles from the United States. How dare China! The reaction from Pacific island states was more measured. While leaders from Tuvalu, Palau and the Solomon Islands strongly criticised the test, the 18-member Pacific Islands Forum...
A Diplomat From Myanmar Refuses to Give Up New York City Post
For more than five years, U Kyaw Moe Tun has refused to give up his United Nations post and a sandstone townhouse on the Upper East Side.
Chinese AI firm Z.ai faces reputation hit after users spot unauthorised uploads
Chinese artificial intelligence company Z.ai is facing a trust crisis after developers discovered that its coding assistant tool, ZCode, was silently uploading local workspace data to external servers without explicit user consent. Even though the company, also known as Zhipu AI, apologised and patched the vulnerability, developers said the incident was likely to weaken its reputation, especially at a time when cybersecurity is becoming a central issue in the AI industry. The issue came to light...
New North Korea-Russia bridge delivers a powerful message to China
The recent opening of a new road bridge between North Korea and Russia may look like a modest infrastructure project. In reality, the 1km stretch across the Tumen River carries implications far beyond the movement of vehicles between two border towns. For China, it is a reminder that its influence over North Korea is no longer as secure as it once appeared and that Russia may be increasingly capable of challenging Beijing’s interests on its northeastern periphery. The bridge, inaugurated on...
North Korea fires 2 missiles in 3 hours amid tensions over US drills
North Korea fired two missiles off its eastern coast on Sunday, its second set of tests in roughly a week and days after Pyongyang accused the US of driving tensions on the Korean peninsula through a series of military drills. Nearly three hours after launching a short-range ballistic missile (SRBM) towards the East Sea, or Sea of Japan, on Sunday afternoon, North Korea fired a similar missile, according to South Korea’s defence ministry. If the subsequent launch is confirmed to be a ballistic...
An Unused and Divisive Philippine Nuclear Plant Awaits Its Fate
The government is exploring nuclear power options to guard against global energy shocks. One proposal is to switch on a plant in Bataan that has been mothballed for 40 years.
China’s CXMT touts new chip manufacturing platform as close to ‘world’s most advanced’
Chinese memory chip giant Changxin Memory Technologies (CXMT) said on Sunday that it adopted its new-generation technology platform for mass production, narrowing the advantage of global leaders including Samsung Electronics and SK Hynix in manufacturing nodes. CXMT’s fifth-generation technology platform, dubbed G5, achieved a “quantum leap” in storage density, with the number of dies produced per wafer increasing by at least 50 per cent from the previous generation while maintaining better...
Middle powers don’t have to wait for a Trump-Xi-Putin summit
The prospect of United States, Chinese and Russian leaders meeting at the Asia-Pacific Economic Cooperation (Apec) summit in Shenzhen this November has revived the Yalta analogy. Talk of a Trump-Xi-Putin summit – echoing the 1945 meeting that reshaped the world – surfaced during the first Trump term, and speculation returned last year with the 80th anniversary of the second world war. No such meeting occurred. However, Chinese President Xi Jinping hosted the two presidents back-to-back in...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.